Endocrine disruptors: Effects on male fertility and screening tools for their assessment

Toxicology in Vitro

Volumn 17, Issue 5-6, 2003, Pages 515-524

  Eertmans, F ^a   Dhooge, W ^a   Stuyvaert, S ^a   Comhaire, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Bioassays; Endocrine disruptors; Male fertility disorders

Indexed keywords

1,1,1 TRICHLORO 2,2 BIS(4 HYDROXYPHENYL)ETHANE; 4 NONYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; ANTIANDROGEN; ANTIESTROGEN; CARCINOGEN; DIETHYLSTILBESTROL; DIOXIN; ESTRADIOL; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; HEPTACHLOR EPOXIDE; HEXACHLOROBENZENE; HORMONE; INDUSTRIAL CHEMICAL; METHOXYCHLOR; MYCOTOXIN; OCHRATOXIN; PESTICIDE; PHTHALIC ACID DERIVATIVE; PHYTOESTROGEN; PLASTICIZER; POLYCHLORINATED BIPHENYL DERIVATIVE; POLYVINYLCHLORIDE; STEROID; STEROID HORMONE; TRIBUTYLTIN; TRICHLOROETHANE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOASSAY; CANCER INCIDENCE; CANCER RISK; CELL PROLIFERATION; CONFERENCE PAPER; CRYPTORCHISM; DEL CASTILLO SYNDROME; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FISH; FROG; GENETIC PREDISPOSITION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPOSPADIAS; IN VITRO STUDY; MALE INFERTILITY; METAMORPHOSIS; NONHUMAN; POLLUTANT; PRENATAL EXPOSURE; RECEPTOR BINDING; REPORTER GENE; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SPERMATOZOON MOTILITY; TESTIS CARCINOMA; TESTIS DISEASE; TOXICITY TESTING; VALIDATION PROCESS;

EID: 0242361638     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(03)00121-8     Document Type: Conference Paper

References (106)

1. Akingbemi B.T., Hardy M.P. Oestrogenic and antiandrogenic chemicals in the environment. effects on male reproductive health Annals of Medicine. 33:2001;391-403.
2. Akre O., Lipworth L., Cnattinguis S., Sparen P., Ekbom A. Risk factor patterns for cryptorchidism and hypospadias. Epidemiology. 10:1999;364-369.
3. Andersen A.G., Jensen T.K., Carlsen E., Jorgensen N., Andersson A.M., Krarup T., Keiding N., Skakkebaek N.E. High frequency of sub-optimal semen quality in an unselected population of young men. Human Reproduction. 15:2000;366-372.
4. Anderson L.M., Diwan B.A., Fear N.T., Roman E. Critical windows of exposure for children's health. cancer in human epidemiological studies and neoplasms in experimental animal models Environmental Health Perspectives. 108:2000;573-594.
5. Ankley G.T., Mihaich E., Stahl R., Tillitt D., Colborn T., McMaster S., Miller R., Bantle J., Campbell P., Denslow N., Dickerson R., Folmar L., Fry M., Giesy J., Gray L.E., Guiney P., Hutchinson T., Kennedy S., Kramer V., LeBlanc G., Mayes M., Nimrod A., Patino R., Peterson R., Purdy R., Ringer R., Thomas P., Touart L., Van der Kraak G., Zacharewski T. Overview of a workshop on screening methods for detecting potential (anti-) estrogenic/androgenic chemicals in wildlife. Environmental Toxicology and Chemistry. 17:1998;68-87.
6. Arnold S.F., Robinson M.K., Notides A.C., Guillette L.J., McLachlan J.A. The weanling male rat as an assay for endocrine disruption: preliminary observations. Environmental Health Perspectives. 104:1996;544-548.
7. Auger J., Jouannet P. Evidence for regional differences of semen quality among fertile French men. Federation Francaise des Centres d'Etude et de Conservation des Oeufs et du Sperme humains. Human Reproduction. 12:1997;740-745.
8. Baskin L.S., Himes K., Colborn T. Hypospadias and endocrine disruption. is there a connection? Environmental Health Perspectives. 109:2001;1175-1183.
9. Bibbo M., Haenszel W.M., Wied G.L., Hubby M., Herbst A.L. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. New England Journal of Medicine. 298:1978;763-767.
10. Boobis A.R., McKillop D., Robinson D.T., Adams D.A., McCormick D.J. Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samples. Xenobiotica. 28:1998;493-506.
11. Bosl G.J., Motzer R.J. Testicular germ-cell cancer. The New England Journal of Medicine. 337:1997;242-253.
12. Branham W.S., Dial S.L., Moland C.L., Hass B.S., Blair R.M., Fang H., Shi L., Tong W., Perkins R.G., Sheehan D.M. Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. Journal of Nutrition. 132:2002;658-664.
13. Carlsen E., Giwercman A., Keiding N., Skakkebaek N.E. Evidence for decreasing quality of semen during past 50 years. BMJ. 305:1992;609-613.
14. Dallinga J.W., Moonen E.J., Dumoulin J.C., Evers J.L., Geraedts J.P., Kleinjans J.C. Decreased human semen quality and organochlorine compounds in blood. Human Reproduction. 17:2002;1973-1979.
15. Davis D.L., Gottlieb M.B., Stampnitzky J.R. Reduced ratio of male to female births in several industrial countries. a sentinel health indicator? JAMA. 279:1998;1018-1023.
16. Dearnaley D., Huddart R., Horwich A. Regular review. Managing testicular cancer BMJ. 322:2001;1583-1588.
17. De Boever P., Demare W., Vanderperren E., Cooreman K., Bossier P., Verstraete W. Optimization of a yeast estrogen screen and its applicability to study the release of estrogenic isoflavones from a soygerm powder. Environmental Health Perspectives. 109:2001;691-697.
18. Del Rio-Gomez I., Marshall T., Tsai P., Shao Y.S., Guo Y.L. Number of boys born to men exposed to polychlorinated byphenyls. Lancet. 360:2002;143-144.
19. Dorfman R. Androgens and anabolic agents. Dorfman R. Methods in Hormone Research, Bioassays II. 1962;275-313 Academic Press, New York.
20. EPA report (2000). Endocrine Disruptor Screening Program.
21. Evans R. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
22. Ewies A.A. Phytoestrogens in the management of the menopause. up-to-date Obstetrical and Gynecological Survey. 57:2002;306-313.
23. Fertuck, K.C. (2002) Complementary In Vitro and In Vivo Rodent Assays. Environmental Protection Agency Endocrine Disruptors Workshop, Screening and Testing Assays Symposium.
24. Fielden M.R., Chen I., Chittim B., Safe S.H., Zacharewski T.R. Examination of the estrogenicity of 2,4,6,2′,6′-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2′,6′-pentachloro-4- biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2′,4′,6′-hexachlorobiphenyl (PCB 155). Environmental Health Perspectives. 105:1997;1238-1248.
25. Fischer B. Receptor-mediated effects of chlorinated hydrocarbons. Andrologia. 32:2000;279-283.
26. Forman D., Møller H. Testicular cancer. Cancer Surveys. 19-20:1994;323-341.
27. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babai D., Portier C.J., McDonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicology and Apllied Pharmacology. 143:1997;205-212.
28. Gaido K.W., Leonard L.S., Maness S.C., Hall J.M., McDonnell D.P., Saville B., Safe S. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors α and β Endocrinology. 140:1999;5746-5753.
29. Gazouli M., Yao Z.X., Boujrad N., Corton J.C., Culty M., Papadopoulos V. Effect of peroxisome proliferators on leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis. role of the peroxisome proliferator-activator receptor α Endocrinology. 143:2002;2571-2583.
30. Goldwyn S., Lazinsky A., Wei H. Promotion of health by soy isoflavones. efficacy, benefit and safety concerns Drug Metabolism and Drug Interaction. 17:2000;261-289.
31. Gray L.E.J., Ostby J., Monosson E., Kelce W.R. Environmental antiandrogens. low doses of the fungicide vinclozolin alter sexual differentiation of the male rat Toxicology and Industrial Health. 15:1999;48-64.
32. Gray L.E.J., Ostby J., Wilson V., Lambright C., Bobseine K., Hartig P., Hotchkiss A., Wolf C., Furr J., Price M., Parks L., Cooper R.L., Stoker T.E., Laws S.C., Degitz S.J., Jensen K.M., Kahl M.D., Korte J.J., Makynen E.A., Tietge J.E., Ankley G.T. Xenoendocrine disrupters-tiered screening and testing. Toxicology. 27:2002;371-382.
33. Greenspan F.S., Gordon J.S. Introduction to endocrinology. Reinhardt S., Langan S. Basic & Clinical Endocrinology. 1997;1-38 Appleton & Lange, Stamford.
34. Gullett B.K., Lemieux P.M., Lutes C.C., Winterrowd C.K., Winters D.L. Emissions of PCDD/F from uncontrolled, domestic waste burning. Chemosphere. 43:2001;721-725.
35. Guo Y.L., Hsu P.C., Hsu C.C., Lambert G.H. Semen quality after prenatal exposure to polychlorinated biphenyls and dibenzofurans. Lancet. 356:2000;1240-1241.
36. Gustafsson J.A. Estrogen receptor beta. a new dimension in estrogen mechanism of action Journal of Endocrinology. 163:1999;379-383.
37. Hershberger, L., Shipley, E. and Meyer, R. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method 83, 1953, 175-180.
38. Hoogenboom L.A.P., DeHaan L., Hooijerink D., Bor G., Murk A.J., Brouwer A. Estrogenic activity of estradiol and its metabolites in the ER-CALUX assay with human T47D breast cells. APMIS. 109:2001;101-107.
39. Hosie S., Loff S., Witt K., Niessen K., Waag K.L. Is there a correlation between organochlorine compounds and undescended testes? European Journal of Pediatric Surgery. 10:2000;304-309.
40. Hotchkiss A.K., Ostby J.S., Vandenburgh J.G., Gray L.E.J. Androgens and environmental antiandrogens affect reproductive development and play behavior in the Sprague-Dawley rat. Environmental Health Perspectives. 110:2002;435-439.
41. Hoyer A.P., Jorgensen T., Brock J.W., Grandjean P. Organochlorine exposure and breast cancer survival. Journal of Clinical Epidemiology. 53:2000;323-330.
42. Hutchinson T.H., Brown R., Brugger K.E., Campbell P.M., Holt M., Lange R., McCahon P., Tattersfield L.J., van Egmond R. Ecological risk assessment of endocrine disruptors. Environmental Health Perspectives. 108:2000;1007-1014.
43. Ibarreta D., Daxenberger A., Meyer H.H. Possible health impact of phytoestrogens and xenoestrogens in food. APMIS. 109:2001;161-184.
44. James W.H. Secular movements in sex ratios of adults and of births in populations during the past half-century. Human Reproduction. 15:2000;1178-1183.
45. Jarrell J.F., Gocmen A., Akyol D., Brant R. Hexachlorobenzene exposure and the proportion of male births in Turkey 1935-1990. Reproductive Toxicology. 16:2002;65-70.
46. Jensen T.K., Toppari J., Keiding N., Skakkebaek N.E. Do environmental estrogens contribute to the decline in male reproductive health? Clinical Chemistry. 41:1995;1896-1901.
47. Juul A., Skakkebaek N.E. Androgens and the ageing male. Human Reproduction Update. 8:2002;423-433.
48. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors. a report of the U.S EPA-sponsored workshop. Environmental Health Perspectives. 104:1996;715-740.
49. Kester M.H., Bulduk S., Tibboel D., Meinl W., Glatt H., Falany C.N., Coughtrie M.W., Bergman A., Safe S.H., Kuiper G.G., Schuur A.G., Brouwer A., Visser T.J. Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites. a novel pathway explaining the estrogenic activity of PCBs Endocrinology. 141:2000;1897-1900.
50. Kirk C.J., Harris R.M., Wood D.M., Waring R.H., Hughes P.J. Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochemical Society Transactions. 29:2001;209-216.
51. Kishida T., Beppu M., Nashiki K., Izumi T., Ebihara K. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2-hydroxyestrone ratio in C3H/HeJ mice. Nutrition and Cancer. 38:2000;209-214.
52. Klip H., Verloop J., van Gool J.D., Koster M.E., Burger C.W., van Leeuwen F.E. Hypospadias in sons of women exposed to diethylstilbestrol in utero. a cohort study Lancet. 359:2002;1102-1107.
53. Kuch H.M., Ballschmiter K. Determination of endocrine-disrupting phenolic compounds and estrogens in surface and drinking water by HRGG-(NCI)-MS in the pictogram per liter range. Environmental Science and Technology. 35:2001;3201-3206.
54. Kuchenhoff A., Seliger G., Klonisch T., Tscheudschilsuren G., Kaltwasser P., Seliger E., Buchmann J., Fischer B. Arylhydrocarbon receptor expression in the human endometrium. Fertility and Sterility. 71:1999;354-360.
55. Kuiper G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β Endocrinology. 139:1998;4252-4263.
56. Lambright C., Ostby J., Bobseine K., Wilson V., Hotchkiss A.K., Mann P.C., Gray L.E.J. Cellular and molecular mechanisms of action of linuron. an antiandrogenic herbicide that produces reproductive malformations in male rats Toxicological Sciences. 56:2000;389-399.
57. Layton A.C., Sanseverino J., Gregory B.W., Easter J.P., Sayler G.S., Schultz T.W. In vitro estrogen receptor binding of PCBs. measured activity and detection of hydroxylated metabolites in a recombinant yeast assay Toxicology and Applied Pharmacology. 180:2002;157-163.
58. Lippman M., Huff K. A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay. Cancer. 38:1976;868-874.
59. Makela T.H., Wahala K.T., Hase T.A. Synthesis of enterolactone and enterodiol precursors as potential inhibitors of human estrogen synthetase (aromatase). Steroids. 65:2000;437-441.
60. Martuzzi M., Di Tanno N.D., Bertollini R. Declining trends of male proportion at birth in Europe. Archives of Environmental Health. 56:2001;358-364.
61. Matthiessen P., Allen Y., Bamber S., Craft J., Hurst M., Hutchinson T., Feist S., Katsiadaki I., Kirby M., Robinson C., Scott S., Thain J., Thomas K. The impact of oestrogenic and androgenic contamination on marine organisms in the United Kingdom-summary of the EDMAR programme. Endocrine disruption in the marine environment. Marine Environmental Research. 54:2002;645-649.
62. McDonnell D.P., Nawaz Z., Densmore C., Weigel N.L., Pham T.A., Clark J.H., O'Malley B.W. High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. Journal of Steroid Biochemistry and Molecular Biology. 39:1991;291-297.
63. McDonnell D.P., Norris J.D. Connections and regulation of the human estrogen receptor. Science. 296:2002;1642-1644.
64. McKiernan J.M., Goluboff E.T., Liberson G.L., Golden R., Fisch H. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. Journal of Urology. 162:1999;361-363.
65. McLachlan J.A., Newbold R.R., Burow M.E., Li S.F. From malformations to molecular mechanisms in the male. three decades of research on endocrine disrupters APMIS. 109:2001;263-272.
66. Meerts I.A., Assink Y., Cenijn P.H., Van Den Berg J.H., Weijers B.M., Bergman A., Koeman J.H., Brouwer A. Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat. Toxicological Sciences. 68:2002;361-371.
67. Metzger D., White J.H., Chambon P. The human estrogen receptor functions in yeast. Nature. 334:1988;31-36.
68. Mocarelli P., Gerthoux P.M., Ferrari E., Patterson D.G.J., Kieszak S.M., Brambilla P., Vincoli N., Signorini S., Tramacere P., Carreri V., Sampson E.J., Turner W.E., Needham L.L. Paternal concentrations of dioxin and sex ratio of offspring. Lancet. 355:2000;1858-1863.
69. Møller H., Cortes D., Engholm G., Thorup J. Risk of testicular cancer with cryptorchidism and with testicular biopsy: cohort study. BMJ. 317:1998;729.
70. Mori C. Possible effects of endocrine disruptors on male reproductive function. Acta Anatomica Nipponica. 76:2001;361-368.
71. Morton M.S., Arisaka O., Miyake N., Morgan L.D., Evans B.A. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. Journal of Nutrition. 132:2002;3168-3171.
72. Norgil D., Main K.M., Toppari J., Skakkebaek N.E. Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction. Best Practice and Research in Clinical Endocrinology and Metabolism. 16:2002;289-309.
73. O'Connor J.C., Cook J.C., Marty M.S., Davis L.G., Kaplan A.M., Carney E.W. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs). Critical Reviews in Toxicology. 32:2002;521-549.
74. Ohlson C.G., Hardell L. Testicular cancer and occupational exposures with a focus on xenoestrogens in polyvinyl chloride plastics. Chemosphere. 40:2000;1277-1282.
75. Olsen G.W., Bodner K.M., Ramlow J.M., Ross C.E., Lipshultz L.I. Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited. Fertility and Sterility. 63:1995;887-893.
76. Owens J.W., Ashby J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists. in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for economic co-operation and development Critical Reviews in Toxicology. 32:2002;445-520.
77. Pajarinen J., Laippala P., Penttila A., Karhunen P.J. Incidence of disorders of spermatogenesis in middle aged Finnish men, 1981-91. two necropsy series BMJ. 314:1997;13-18.
78. Parks L.G., Lambright C.S., Orlando E.F., Guillette L.J.J., Ankley G.T., Gray L.E.J. Masculinization of female mosquitofish in Kraft mill effluent-contaminated Fenholloway River water is associated with androgen receptor agonist activity. Toxicological Sciences. 62:2001;257-267.
79. Paulozzi L.J., Erickson J.D., Jackson R.J. Hypospadias trends in two US surveillance systems. Pediatrics. 100:1997;831-834.
80. Petersen P.M., Giwercman A., Skakkebaek N.E., Rorth M. Gonadal function in men with testicular cancer. Seminars in Oncology. 25:1998;224-233.
81. Rasmussen T.H., Nielsen J.B. Critical parameters in the MCF-7 cell proliferation bioassay (E-Screen). Biomarkers. 7:2002;322-336.
82. Rier S.E., Martin D.C., Bowman R.E., Dmowski W.P., Becker J.L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundamental and Applied Toxicology. 21:1993;433-441.
83. Routledge E.J., Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products assesses using a recombinant yeast screen. Environmental Toxicology and Chemistry. 15:1996;241-248.
84. Schwartz G.G. Hypothesis. does ochratoxin A cause testicular cancer? Cancer Causes Control. 13:2002;91-100.
85. Shafie S., Brooks S.C. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7). Cancer Research. 37:1979;792-799.
86. Sharpe R.M., Skakkebaek N.E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 341:1993;1392-1395.
87. Sharpe R.M. The 'oestrogen hypothesis' - where do we stand now? International Journal of Andrology. 26:2003;2-15.
88. Skakkebaek N.E., Rajpert-De M.E., Main K.M. Testicular dysgenesis syndrome. an increasingly common developmental disorder with environmental aspects Human Reproduction. 16:2001;972-978.
89. Sohoni P., Sumpter J.P. Several environmental oestrogens are also anti-androgens. Journal of Endocrinology. 158:1998;327-339.
90. Soto A.M., Justicia H., Wray J.W., Sonnenschein C. p-Nonyl-phenol. an estrogenic xenobiotic released from "modified" polystyrene Environmental Health Perspectives. 92:1991;167-173.
91. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-SCREEN assay as a tool to identify estrogens. an update on estrogenic environmental pollutants Environmental Health Perspectives. 103:1995;113-122.
92. Sumpter J.P. Xenoendorine disrupters. environmental impacts Toxicology Letters. 28:1998;337-342.
93. Swan S.H., Elkin E.P., Fenster L. Have sperm densities declined? A reanalysis of global trend data. Environmental Health Perspectives. 105:1997;1228-1232.
94. Swerdloff R.S., Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto A.M., Snyder P.J., Weber T., Longstreth J., Berman N. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. Journal of Clinical Endocrinology Metabolism. 85:2000;4500-4510.
95. Tabak H.H., Bunch R.L. Steroid hormones as water pollutants I. metabolism of natural and synthetic ovulation inhibiting hormones by microorganisms of activated sludge and primary settled sewage Developments in Industrial Microbiology. 11:1970;367-376.
96. Ternes T.A., Kreckel P., Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants-II. Aerobic batch experiments with activated sludge. The Science of the Total Environment. 225:1999;91-99.
97. Tietge J.E., Ankley G.T., Degitz S.J. Report on the Xenopus Tail Resorption Assay as a Tier 1 Screen for Thyroid Active Chemicals. 2000;Mid-Continent Ecology Division, USEPA, Duluth, MN. 45.
98. Toppari J., Kaleva M., Virtanen H.E. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Human Reproduction Update. 7:2001;282-286.
99. Traish A.M., Muller R.E., Wotiz H.H. Binding of 7α, 17α-dimethyl-19-nortestosterone to androgen and progesterone receptors in human and animal tissues. Endocrinology. 118:1986;1327-1333.
100. Van Waeleghem K., De Clercq N., Vermeulen L., Schoonjans F., Comhaire F. Deterioration of sperm quality in young healthy Belgian men. Human Reproduction. 11:1996;325-329.
101. Warner M., Eskenazi B., Mocarelli P., Gerthoux P.M., Samuels S., Needham L., Patterson D., Brambilla P. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environmental Health Perspectives. 110:2002;625-628.
102. Weidner I.S., Møller H., Jensen T.K., Skakkebaek N.E. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environmental Health Perspectives. 106:1998;793-796.
103. Wong C., Kelce W.R., Sar M., Wilson E.M. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. Journal of Biological Chemistry. 25:1995;19998-20003.
104. Yaoita Y., Nakajima K. Induction of apoptosis and CPP32 expression by thyroid hormone in a myoblastic cell line derived from tadpole tail. Journal of Biological Chemistry. 272:1997;5122-5127.
105. Zacharewski T.R. In vitro bioassays for assessing estrogenic substances. Environmental Science & Technology. 31:1997;613-623.
106. 3H] methyltrienolone in the presence and absence of progesterone receptors. Endocrinology. 104:1979;1007-1012.